Please note that our office will be closed from December 25, 2014 to January 2, 2015, inclusive.
News & Events
22
Dec2014
14
Nov2014
Included in this edition are:
PMPRB Town Hall Meeting
PMPRB Staff held a Town Hall meeting on October 1 at the Ottawa Convention Centre. Discussions involved PMPRB Staff taking a fresh look at the organization’s vision and mandate, potential new strategic priorities for the PMPRB and how to operationalize them moving forward. ... Read More
06
Nov2014
ONTARIO
Proposed Regulation Amendments to Establish a Pricing Framework for Generic Products
An Ontario Public Drug Programs Executive Officer Communication published on November 5, 2014 invites stakeholder comments on proposed amendments to O. Reg. 201/96 under the Ontario Drug Benefit Act. The proposed amendments would establish a pricing framework for ... Read More
03
Nov2014
Date Posted:
November 3, 2014
Location:
Ottawa, Ontario
Job Title:
Pricing & Market Access Associate
Reports To:
Director, Pricing & Market Access
Employment Type:
Full-time
Website:
pdci.ca/about-us/careers/
For more information regarding this position or any other career opportunities with PDCI, please visit our careers page.
03
Nov2014
PMPRB
The Chairperson of the Board has approved a Voluntary Compliance Undertaking submitted by Valeant Canada LP regarding the price of Lodalis (colesevelam hydrochloride).
For more information regarding the VCU, please consult the PMPRB website.
24
Oct2014
The next PMPRB OUTREACH Sessions will be held on Tuesday, December 2, 2014 in Montreal, followed by Wednesday, December 3, 2014 in Toronto.
Rumoured topics to be covered include:
Changes to current international price source formularies referenced by Board Staff (specifically Germany)
Supplementary price sources
Updates on Form 2 regulatory amendments undergoing Canada Gazette ... Read More
22
Oct2014
QUEBEC
Meetings with Manufacturers for the June 2015 “Liste des médicaments”
As part of the June 2015 updates to the “Liste des medicaments,” INESSS will meet with manufacturers who have made submissions before the deadline.
These meetings with take place between December 15-19, 2014 and January 5-9, 2015 inclusively and will cover:
Discussions on ... Read More
16
Oct2014
Pan-Canadian Pharmaceutical Alliance (pCPA) has posted the IBM Report on its website
The much anticipated IBM report (entitled “Pan Canadian Drugs Negotiation Report”) has now been posted on the pCPA website.
The objectives of the IBM engagement include:
Recommending options for the development of a permanent model that will facilitate negotiations for brand ... Read More
08
Oct2014
We are pleased to announce that effective October 6, 2014 Anita Carrie has joined PDCI Market Access Inc as a Senior Consultant as part of the HTA and Clinical Evaluation team.
Most recently Anita has been working at the CADTH Common Drug Review (CDR) where she held several senior roles, including ... Read More
03
Oct2014
Common Drug Review patient input submission system
CADTH has added new safeguards allowing them to better track submissions automatically:
Online & email confirmations for successful uploads
Submissions can now be uploaded until midnight on the date of the specified deadline, in all Canadian time zones
2015 CADTH Symposium
CADTH is offering funding to help patient ... Read More